Join to View Full Profile
615 N Wolfe StBaltimore, MD 21205
Phone+1 410-955-9601
Fax+1 410-614-8263
Are you Dr. Markham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Markham, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1977 - 1979
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1973 - 1975
Albert Einstein College of MedicineClass of 1972
Certifications & Licensure
MD State Medical License 1976 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- MIP-3α-antigen fusion DNA vaccine enhances sex differences in tuberculosis model and alters dendritic cell activity early post vaccination.James T Gordy, Rowan E Bates, Elizabeth Glass, Jacob Meza, Yangchen Li
Research Square. 2025-01-14 - Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ ...Kaitlyn Fessler, Jiaqi Zhang, Avinaash K Sandhu, Yinan Hui, Aakanksha R Kapoor
Journal of Immunotherapy. 2025-01-01 - Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD1...Kaitlyn Fessler, Jiaqi Zhang, Avinaash K Sandhu, Yinan Hui, Aakanksha R Kapoor
Research Square. 2024-08-20
Grant Support
- Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persistersJOHNS HOPKINS UNIVERSITY2020–2025
